Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Both the India and GCC entities will be operated by separate dedicated management teams
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
The Product will be manufactured at the company's facility in Bengaluru
Evinova will operate as a separate health-tech business within AstraZeneca
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
The company has raised US$4.5 million in funding for its AI operating system
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Subscribe To Our Newsletter & Stay Updated
